Provided by Tiger Trade Technology Pte. Ltd.

INNOCARE

12.040
+0.2802.38%
Volume:9.33M
Turnover:111.94M
Market Cap:21.21B
PE:-40.82
High:12.350
Open:11.800
Low:11.780
Close:11.760
52wk High:20.620
52wk Low:6.890
Shares:1.76B
HK Float Shares:1.49B
Volume Ratio:1.24
T/O Rate:0.62%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.295
ROE:-3.55%
ROA:-2.10%
PB:2.81
PE(LYR):-40.82
PS:13.10

Loading ...

HK Stock Movement | INNOCARE (09969) Rises Over 4% as Self-Developed Novel TYK2 Inhibitor ICP-332 Gains Approval for Phase II/III Clinical Trials in CSU Treatment

Stock News
·
Dec 19, 2025

InnoCare Pharma Receives Regulatory Approval to Begin Clinical Trial of Drug in Systemic Lupus

MT Newswires Live
·
Dec 15, 2025

InnoCare Pharma (SEHK:9969): Assessing Valuation After Landmark NTRK Solid-Tumor Approval for Zurletrectinib

Simply Wall St.
·
Dec 15, 2025

Innocare Pharma Limited (688428.SH): Orelabrutinib Meets Primary Endpoint in Phase IIb Study for Systemic Lupus Erythematosus

Stock News
·
Dec 14, 2025

First Solid-Tumor Drug Approval Might Change The Case For Investing In InnoCare Pharma (SEHK:9969)

Simply Wall St.
·
Dec 13, 2025

HK Stock Movement | INNOCARE (09969) Rises Over 3% as NDA Submission for Zorletinib in Pediatric Patients Expected Soon

Stock News
·
Dec 12, 2025

Everest Medicines (01952) Announces Strategic Collaboration with Haisco; Silver Prices Hit Record High

Stock News
·
Dec 12, 2025

InnoCare Pharma Gets China Nod for Tumor Drug

MT Newswires Live
·
Dec 11, 2025

InnoCare Pharma (09969) Releases Monthly Return for 30 November 2025, No Changes in Share Capital

Bulletin Express
·
Dec 04, 2025

InnoCare Pharma (SEHK:9969) Valuation in Focus After Revenue Growth and Narrowed Losses

Simply Wall St.
·
Nov 27, 2025

Earnings Update: InnoCare Pharma Limited (HKG:9969) Just Reported Its Interim Results And Analysts Are Updating Their Forecasts

Simply Wall St.
·
Nov 16, 2025

InnoCare Pharma (SEHK:9969): Evaluating Valuation After Sales Growth and Pipeline Advances Spark Market Interest

Simply Wall St.
·
Nov 14, 2025

InnoCare Pharma Logs Over 34 Million Yuan in Q3 Loss

MT Newswires Live
·
Nov 13, 2025

InnoCare Pharma Limited (9969) Releases 2025 Third Quarter Results and Updates Nomination Committee

Bulletin Express
·
Nov 13, 2025

Innocare Pharma Limited (688428.SH) Reports Q3 Results with Net Loss of 64.41 Million Yuan

Stock News
·
Nov 13, 2025

InnoCare Pharma Limited (09969) Announces Monthly Securities Movements for October 2025

Bulletin Express
·
Nov 05, 2025

How Investors May Respond To InnoCare Pharma (SEHK:9969) Advancing Novel B7-H3 ADC and Next-Gen TRK Inhibitor

Simply Wall St.
·
Nov 02, 2025

InnoCare Pharma Insider Lowered Holding By 89% During Last Year

Simply Wall St.
·
Nov 01, 2025

HK Short Interest Data as of October 31

Stock News
·
Oct 31, 2025

InnoCare Pharma (9969) Schedules Board Meeting for Third-Quarter 2025 Results

Bulletin Express
·
Oct 31, 2025